Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
出版年份 2015 全文链接
标题
Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
作者
关键词
-
出版物
HEPATOLOGY
Volume 62, Issue 4, Pages 1160-1173
出版商
Wiley
发表日期
2015-07-07
DOI
10.1002/hep.27968
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Upregulation of TLRs and IL-6 as a Marker in Human Colorectal Cancer
- (2014) Chien-Chang Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer stem cells in the development of liver cancer
- (2013) Taro Yamashita et al. JOURNAL OF CLINICAL INVESTIGATION
- Sorafenib Inhibits Hypoxia-Inducible Factor-1 Synthesis: Implications for Antiangiogenic Activity in Hepatocellular Carcinoma
- (2012) L.-p. Liu et al. CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
- (2011) Terence Kin Wah Lee et al. Cell Stem Cell
- CENP-C Is a Structural Platform for Kinetochore Assembly
- (2011) Marcin R. Przewloka et al. CURRENT BIOLOGY
- Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice
- (2011) Chao Wang et al. HEPATOLOGY
- CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
- (2011) Kwan Ho Tang et al. HEPATOLOGY
- MAP4 and CLASP1 operate as a safety mechanism to maintain a stable spindle position in mitosis
- (2011) Catarina P. Samora et al. NATURE CELL BIOLOGY
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
- (2010) Stephanie Ma et al. Cell Stem Cell
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Hepatitis B and hepatocellular carcinoma
- (2010) Adrian M. Di Bisceglie HEPATOLOGY
- Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells
- (2010) Laura D'Anello et al. Molecular Cancer
- Sorafenib Inhibits STAT3 Activation to Enhance TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
- (2010) S. Huang et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
- (2010) Anne M Friel et al. Reproductive Biology and Endocrinology
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib
- (2009) Adam D. Lipworth et al. ONCOLOGY
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- (2008) E. A. Nelson et al. BLOOD
- Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
- (2008) W. Song et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Progenitor/stem cells give rise to liver cancer due to aberrant TGF- and IL-6 signaling
- (2008) Y. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now